Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

15.26
Delayed Data
As of May 05
 +0.02 / +0.13%
Today’s Change
14.07
Today|||52-Week Range
18.04
-5.80%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close15.24
Today’s open15.29
Day’s range15.09 - 15.31
Volume1,264,940
Average volume (3 months)1,271,446
Market cap$4.1B
Dividend yield2.38%
Data as of 05/05/2016

Growth & Valuation

Earnings growth (last year)-5.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.65%
Revenue growth (last year)-2.06%
P/E ratio--
Price/Sales2.56
Price/Book3.04

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-0.26-0.61%
ACADACADIA Pharmaceutica...-0.48-1.74%
ICPTIntercept Pharmaceut...-2.14-1.54%
UTHRUnited Therapeutics ...-0.43-0.40%
Data as of 05/05/2016

Financials

Last reporting dateMay 6, 2016
EPS forecast (this quarter)$0.28
Annual revenue (last year)$4.3B
Annual profit (last year)$587.3M
Net profit margin13.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Víctor Grifols Roura
Chief Financial Officer &
Vice President
Alfredo Arroyo Guerra
Corporate headquarters
Barcelona, Catalonia

Forecasts

Partner Offers

Search for Jobs